Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-70
SponsorWonju Severance Christian Hospital

About this trial

The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments?

Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery.

Participants will:

* Receive ERAS protocol during the hospitalization * Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7 * Visit the hospital at one week and one month after discharge * Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 20 and 70 years

Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia

Use of an Android smartphone

Disqualifiers

American Society of Anesthesiologists(ASA) physical status classification IV or higher

Body Mass Index (BMI) 35 or higher

Presence of diabetic autonomic neuropathy

History of esophageal hiatal hernia or delayed stomach discharge

Trial design

Design model

Parallel

Treatments tested in this trial

  • Enhanced Recovery After Surgery

    Procedure/Surgery

    1. Before surgery * Sips of water until 6 AM on the day of surgery, followed by a 200 mL carbohydrate drink * Pre-emptive oral analgesics (celecoxib 200mg 1 cap + acetaminophen 650mg 2 tab) 2. During surgery * Total intravenous anesthesia * Local anesthetic infiltration at the laparoscopic port site for post-operative pain control 3. After surgery * Sips of water and a foley catheter removal on ward arrival * Soft meal 4 housr after surgery * General diet 8 hours after surgery

  • Usual Care

    Procedure/Surgery

    1. Before surgery * Midnight NPO * No pre-emptive analgesics 2. During surgery * Balanced anesthesia 3. After surgery * Sips of water 8 hours after arrival in the ward * Foley catheter removal one day after the surgery * Soft meal after gas out * General diet after one soft meal

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: ERASExperimental treatment 1 intervention
Group B: ConventionalActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Quality of Recovey-15, Korean version (QoR-15K)

This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.

Time frame
on 24 hours postoperatively
2

Quality of Recovey-15, Korean version (QoR-15K)

This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.

Time frame
one week after hospital discharge
3

Quality of Recovey-15, Korean version (QoR-15K)

This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.

Time frame
one month after hospital discharge
4

The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)

WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.

Time frame
on 24 hours postoperatively

Secondary outcomes

1

Pain (Visual analogue scale)

The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.

Time frame
on 24 hours postoperatively
2

Pain (Visual analogue scale)

The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.

Time frame
1 week after hospital discharge
3

Pain (Visual analogue scale)

The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.

Time frame
1 month after hospital discharge
4

Length of stay

Time frame
throughout hospitalization, expected to be 2-3 days

Other outcomes

1

Heart rate variability

measured from wearable electrocardiography and a smart watch

Time frame
From discharge day to one month after discharge

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Wonju Severance Christian Hospital

Lead sponsor

Ministry of Trade, Industry & Energy, Republic of Korea

Collaborator

This trial is not recruiting at the moment. You can still explore other options: